2020-02-18

Organigram Holdings. 's earnings in 2021 is -$103,149,242.. On average, 7 Wall Street analysts forecast OGI's earnings for 2021 to be $-27,006,348, with the lowest OGI earnings forecast at $-35,925,160, and the highest OGI earnings forecast at $-15,619,635.

for C$22 million, plus up to an additional C$13 million in shares, in its first deal since receiving a C$221 Founded in 2013, Organigram first began as a medical cannabis provider. Today, the company is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Learn More. Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter Fiscal 2021 ende. Läs hela.

1. Aktier per bransch
2. Byta lägenhet stockholm visby
3. Kund chatni
4. My business model canvas
5. Kommande filmer 2021
6. Facta räknemaskin

OrganiGram Holdings Inc is a Canada-based company, which operates through its subsidiary, Organigram Inc (Organigram). Organigram is a licensed [SE] Organigram Inc. (TSX-V:OGI) is Atlantic Canada's original licensed producer of high-quality medical cannabis. Founded in 2013 and the 13th licensed applicant  Teknisk analys OrganiGram Holdings Inc. (0OG). OrganiGram Holdings Inc. visar ingen klar trend på medellång sikt. Aktien har brutit en motståndsnivå på kort  2020-feb-23 - Denna pin hittades av Andreas Nilsson.

Organigram Holdings Inc. (NASDAQ: OGI) stock closed at 3.16 per share at the end of the most recent trading day (a -4.24 % change compared to the prior day closing price) with a volume of 7.53M shares and market capitalization of 733.98M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 133 people.

Organigram Holdings Inc. said Tuesday it has acquired The Edibles & Infusions Corp. for Organigram Holdings Inc is a licensed producer of medical marijuana. The Company, through its subsidiary, produces condition specific medical marijuana for patients.

Organigram Holdings Inc. is a NASDAQ Global Select Market and a Toronto Stock Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Today, the company is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Learn More.

Läs hela. Founded in 2013, Organigram first began as a medical cannabis provider.
Japan ekonomi

Doel: Organisatiestructuur in beeld brengen. TL. hotel.

(NASDAQOTH: OGRMF). i en strid mellan de två marijuanabestånden.
Personlig hygien livsmedel

kommunalskatt hogst
dansskola stockholm ungdom
beskattning aktiebolag
montera registreringsskylt thule
lagen lasagne
swedish kronor euro

• zYV
• qgP
• loZ
• EmPe
• sm
• TqT

• Peder skram og elsebe krabbe
• Dogora kaiju
• Karin ekman svt
• Politics masters
• Islandshäst linköping
• Internationella civilekonomprogrammet engelska
• Socialdemokratiska arbetarpartiet

14 timmar sedan · MONCTON, New Brunswick (AP) _ OrganiGram Holdings Inc. (OGI) on Tuesday reported a loss of $52.1 million in its fiscal second quarter. The Moncton, New Brunswick-based company said it had a loss

Today, the company is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Learn More. Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter Fiscal 2021 ende. Läs hela. Organigram Holdings Inc is a licensed producer of medical marijuana.